Results 171 to 180 of about 94,721 (312)
Drug hypersensitivity leading to emergency department visit: a comprehensive analysis of clinical features and management. [PDF]
Chung SJ +5 more
europepmc +1 more source
Deep Caries Management: EFCD‐ESE‐ORCA S3‐Level Clinical Practice Guideline
ABSTRACT Objective To develop an evidence‐based S3‐level clinical practice guideline for the management of deep and extremely deep caries in vital permanent teeth. Methods An evidence‐based medical guideline based on systematically searched and appraised evidence as well as a structured consensus (S3‐level) was jointly developed by the European ...
Falk Schwendicke +11 more
wiley +1 more source
Delayed hypersensitivity reactions to taxanes: Clinical presentation and outcomes of post-medication and rapid drug desensitization. [PDF]
Villarreal-González R +6 more
europepmc +1 more source
Severe Hair Dye Anaphylaxis Caused by Toluene‐2,5‐ Diamine Identified by Positive in Vitro Tests
Contact Dermatitis, EarlyView.
Eglė Janušonytė +3 more
wiley +1 more source
ABSTRACT Background Pulse oximetry is an accurate diagnostic method for assessing the condition of the dental pulp; however, the normal oxygen saturation levels for each tooth type are yet to be clearly defined. Objectives This systematic review and meta‐analysis aims to answer the question: What are the reference values for pulse oximetry testing in ...
Lilian Tietz +3 more
wiley +1 more source
Unveiling the Uncommon: A Rare IgE-Mediated Presentation of Multiple Drug Hypersensitivity Syndrome. [PDF]
Soares AV +4 more
europepmc +1 more source
Abstract Background There is no published information on the recognition and management of anaphylaxis in regional Queensland. The establishment of a clinical immunology and allergy service for the Cairns and Hinterland Hospital and Health Service (CHHHS) has enabled the exploration of patient outcomes.
Kane Langdon +2 more
wiley +1 more source
Infusion-related reactions in donanemab-treated participants with early symptomatic Alzheimer's disease. [PDF]
Ardayfio P +16 more
europepmc +1 more source
Dupilumab treatment in children aged 6 months to 5 years with severe atopic dermatitis
The results of this French Early Access Program were consistent with those reported in dupilumab randomized clinical trials in children aged 6 months–5 years with moderate‐to‐severe AD. This research offers insights into the practical use of dupilumab in routine clinical practice.
Audrey Lasek +9 more
wiley +1 more source
Abdulbasit A Al-Ghoury,1,2 Jamil MAS Obaid,1,3 Waheed A Ali,4 Mohammed A Al-Shaybani5 1Laboratory Medicine Department, Faculty of Medicine and Health Sciences, Emirates International University, Sana’a, Yemen; 2Laboratory Medicine Department, Faculty of ...
Al-Ghoury AA +3 more
doaj

